skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Can I have your thoughts on ZDI or an alternative you suggest. Yield and holdings look good. Also, what do you suggest as a foreign stock holding percentage for a portfolio not including US stocks. Looking to add foreign dividends and exposure with existing incoming Canadian dividends from portfolio. Does ZDI hold the stocks directly or through another ETF, I want to get as close as I can to the ownership of the stocks through the ETF avoiding any unnecessary extra fees.
Read Answer Asked by Nino on November 30, 2016
Q: I have a question about the effect of demonetization on Indian stocks in the short term and medium term. I currently own ZID ETF (down 10%), ICICI Bank IBN (breaking even) and Dr Reddy's lab RDY (down 8%). Should I continue to hold? Would appreciate your views on these.

Thanks
Read Answer Asked by satish on November 25, 2016
Q: Hi,
Ive own a few etfs (vgg and vfv). I have some other individual stocks as well, but the majority of my portfolio is in the etfs looking for long term growth. I have been thinking about adding emerging markets but am having a hard time rationalizing it. I saw that a few days ago you recommended VEE. Can you explain the value of this etf, or is there a better way to get some emerging markets exposure? VEE opened at 24.65 4 years ago and has been up and down a little, but is only at 28.84 today. Is 4 years not thinking long enough for this? Im just having a hard time seeing the value of adding it to my account since VFV has doubled and VFV is up 65% in less time.

Thanks!
Read Answer Asked by david on November 18, 2016
Q: I have held Novartis for a few years and still show a profit of ~33%. However it has dropped significantly in the last 18 months. In the pharma space, I also hold Knight Therapeutic (GUD) and Johnson & Johnson (JNJ). I wonder if Novartis is still worth keeping or should I consider switching to something else (or increasing my holding in J&J or GUD). It represents ~1% of my portfolio which is well diversified but light on pharma. Although not your primary field of expertise, I would still appreciate any light you could shed on the company. Thank you for your valuable insights.
Read Answer Asked by jacques on November 18, 2016
Q: I'd like to get equity exposure outside North America through some ETFs. Could you recommend a few ETFs that would provide sufficient diversification across the rest of the world? Where should I focus? Europe? Emerging Markets?

Thanks,
Jason
Read Answer Asked by Jason on November 07, 2016